In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1

Usman Sumo Friend, Rizky Archintya Rachmania, Arli Aditya Parikesit

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The docking result showed that AD3BF2D ligand (N-[(1S,6R)-5-amino-5-{[(2R,3S,4S)-3,4-dihydroxy-4-(hydroxymethyl) tetrahydrofuran-2-yl]oxy}-4-formylcyclohex-3-en-1-yl]acetamide-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate) had better binding energy values than standard oseltamivir. AD3BF2D had several interactions, including hydrogen bonds, with the residues in the catalytic site of neuraminidase as identified by molecular dynamics simulation. The results showed that AD3BF2D ligand can be used as a good candidate for neuraminidase inhibitor to cope with influenza A virus subtype H1N1.

Original languageEnglish
Pages (from-to)150-159
Number of pages10
JournalJournal of Biomedical Research
Volume29
Issue number2
DOIs
Publication statusPublished - 1 Jan 2015

Keywords

  • Influenza
  • Influenza A virus subtype (H1N1)
  • Molecular docking
  • Molecular dynamics simulation
  • Oseltamivir

Fingerprint Dive into the research topics of 'In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1'. Together they form a unique fingerprint.

Cite this